This document presents the final re-evaluation decision for the re-evaluation of quizalofop-p-ethyl, including the required amendments (risk mitigation measures) to protect human health and the environment, as well as label amendments required to bring labels to current standards. All products containing quizalofop-p-ethyl that are registered in Canada are subject to this re-evaluation decision… Read More
